课题基金 / 基金详情

Microenvironmental strategies for the optimal utilization of anti-angiogenic drugs combinations

Microenvironmental strategies for the optimal utilization of anti-angiogenic drugs combinations
最佳利用抗血管生成药物组合的微环境策略
批准号：
240119
负责人：
Minchinton Andrew I
金额：
$48.27万
依托单位：
B.C. Cancer Research Centre (Vancouver)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2011
资助国家：
加拿大
项目状态：
已结题
起止时间：
2011-09-01 至 2015-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=240119&lang=en
关键词：
Angiogenesis Chemotherapy Hypoxia Radiation Therapy Tumour Microenvironment

项目摘要

项目成果

Minchinton Andrew I的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Anti-angiogenic therapy involves treatments with drugs that inhibit the growth of blood vessels. In adults angiogenesis only occurs during wound healing, inflammation and a few other instances. Tumour growth necessitates new blood vessel development to fe
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of clinical candidate hypoxia-activated DNA-PK inhibitors
FLASH radiotherapy - mechanisms and translational studies
Metabolic manipulation of hypoxia for improved radiotherapy response
Hypoxia-activated DNA repair inhibitors to improve cancer therapy
海外基金